An Open Label, Multiple Dose Study to Investigate the Pharmacokinetics of Omecamtiv Mecarbil Administered Orally to Patients With Stable Heart Failure

Trial Profile

An Open Label, Multiple Dose Study to Investigate the Pharmacokinetics of Omecamtiv Mecarbil Administered Orally to Patients With Stable Heart Failure

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 27 May 2011

At a glance

  • Drugs Omecamtiv mecarbil (Primary)
  • Indications Heart failure
  • Focus Pharmacokinetics
  • Most Recent Events

    • 27 May 2011 Planned end date changed from 1 Oct 2011 to 1 May 2011 as reported by ClinicalTrials.gov
    • 27 May 2011 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov
    • 30 Sep 2010 Planned end date changed from 1 May 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top